Essilor Intl ADR (ESLOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ESLOY | ABT | BSX | ||
| Company | Essilor Intl ADR | Abbott Laboratories | Boston Scientific Corp | ||
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | ||
| Open | 158.8900 | 124.58 | 96.14 | ||
| High | 159.7600 | 125.19 | 96.31 | ||
| Low | 158.4700 | 124.26 | 95.81 | ||
| Latest | 159.3500 | 124.84 | 96.06 | ||
| Change | +0.7500 | +0.03 | -0.07 | ||
| % Change | +0.47% | +0.02% | -0.07% | ||
| Volume | 24,000 | 2,120,800 | 3,295,100 | ||
| 20-Day Average Volume | 43,165 | 5,769,050 | 9,665,615 | ||
| Previous Close | 158.6000 | 124.81 | 96.13 | ||
| Industry | Medical Products | Medical Products | Medical Products | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 168.3835 | 125.28 | 95.74 | ||
| 20-Day Raw Stochastic | 11.53% | 45.25% | 49.09% | ||
| 20-Day Relative Strength | 33.86 | 46.29 | 47.04 | ||
| Weighted Alpha | +23.61 | +3.27 | +0.62 | ||
| Today's Opinion | 24% Buy | 100% Sell | 88% Sell | ||
| Previous Opinion | 24% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 80% Buy | 88% Sell | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.64% since 12/18/25 | -0.22% since 12/18/25 | -0.05% since 12/18/25 | ||
| Low | 156.5900 on 12/24/25 | 123.76 on 12/19/25 | 95.20 on 12/22/25 | ||
| High | 162.2675 on 12/19/25 | 127.24 on 12/22/25 | 97.27 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | -12.23% since 11/26/25 | -2.88% since 11/26/25 | -4.85% since 11/26/25 | ||
| Low | 156.5900 on 12/24/25 | 120.70 on 12/10/25 | 90.42 on 12/16/25 | ||
| High | 180.5200 on 12/03/25 | 129.85 on 12/01/25 | 101.91 on 12/01/25 | ||
| 3-Month | |||||
| %Chg | +0.08% since 09/26/25 | -6.52% since 09/26/25 | -2.16% since 09/26/25 | ||
| Low | 155.9400 on 10/15/25 | 120.70 on 12/10/25 | 90.42 on 12/16/25 | ||
| High | 186.8100 on 11/13/25 | 135.45 on 10/01/25 | 105.65 on 11/13/25 | ||
| 6-Month | |||||
| %Chg | +17.72% since 06/26/25 | -6.61% since 06/26/25 | -8.15% since 06/26/25 | ||
| Low | 135.9200 on 06/30/25 | 119.77 on 07/17/25 | 90.42 on 12/16/25 | ||
| High | 186.8100 on 11/13/25 | 137.49 on 09/22/25 | 109.50 on 09/09/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 146,909,760 | 217,028,608 | 142,507,152 | ||
| Shares Outstanding, K | 926,291 | 1,738,872 | 1,482,442 | ||
| Annual Sales | 28,684,310,000 | 41,950,000,000 | 16,747,000,000 | ||
| Annual Net Income | 2,552,670,000 | 13,402,000,000 | 1,854,000,000 | ||
| Last Quarter Sales | N/A | 11,369,000,000 | 5,065,000,000 | ||
| Last Quarter Net Income | N/A | 1,644,000,000 | 755,000,000 | ||
| 60-Month Beta | 1.03 | 0.72 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.30 on 10/15/25 | 0.75 on 10/22/25 | ||
| Latest Earnings Date | 01/01/70 | 01/28/26 | 02/04/26 | ||
| Most Recent Dividend | 1.621 on 05/12/25 | 0.590 on 10/15/25 | N/A | ||
| Next Ex-Dividends Date | 05/12/25 | 01/15/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.96 | 32.57 | ||